Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 22% on Friday after reporting results in a late-stage trial that missed expectations.
Related Posts
Middle East Crisis: U.N. Presses Israel to Help in Delivering Aid to Gaza
Agencies are struggling to deliver food and other basic necessities, and a report concluded that the territory was at high…
Trump says Zelenskyy ‘is not ready for peace’ after Oval Office fight
President Donald Trump and Vice President JD Vance argued with Ukraine President Volodymyr Zelenskyy, with Vance accusing Zelenskyy of disrespect.
Intel is getting a $2 billion investment from SoftBank
SoftBank will pay $23 per share for Intel’s common stock, acquiring roughly 2% of the struggling chipmaker.